Smith & Nephew plc(SNN)Earnings, Financials & Key Ratios
SNN•NYSE
$31.31
$13.29B mkt cap·21.7× P/E·Price updated May 6, 2026
AboutSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.Show more
- Revenue$6.18B+6.3%
- EBITDA$1.58B+27.7%
- Net Income$626M+52.1%
- EPS (Diluted)1.44+53.2%
- Gross Margin68.01%-2.3%
- EBITDA Margin25.57%+20.1%
- Operating Margin16.27%+43.9%
- Net Margin10.14%+43.0%
- ROE11.87%+51.0%
- ROIC9.41%+52.4%
- Debt/Equity0.63-0.3%
- Interest Coverage6.43+64.4%
SNN Key Insights
Smith & Nephew plc (SNN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 2.4%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SNN Price & Volume
Smith & Nephew plc (SNN) stock price & volume — 10-year historical chart
Loading chart...
SNN Growth Metrics
Smith & Nephew plc (SNN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.92%
5 Years6.26%
3 Years5.81%
TTM9.95%
Profit CAGR
10 Years4.33%
5 Years6.94%
3 Years41.1%
TTM11.86%
EPS CAGR
10 Years4.58%
5 Years7.14%
3 Years42.28%
TTM14.2%
Return on Capital
10 Years9.14%
5 Years6.98%
3 Years8.21%
Last Year11.37%
SNN Recent Earnings
Smith & Nephew plc (SNN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Mar 3, 2026EPS
$1.18
Est $1.16
+1.7%
Revenue
$3.2B
Est $2.8B
+15.5%
Q2 2026
Mar 2, 2026EPS
$1.18
Est $1.16
+1.7%
Revenue
$3.2B
Est $2.8B
+15.5%
Q3 2025
Aug 5, 2025EPS
$0.67
Est $0.86
-21.7%
Revenue
$3.0B
Est $1.5B
+98.0%
Q1 2025
Feb 25, 2025EPS
$0.23
Est $0.92
-75.5%
Revenue
$3.0B
Est $1.5B
+96.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 3, 2026 | $1.18vs $1.16+1.7% | $3.2Bvs $2.8B+15.5% |
| Q2 2026 | Mar 2, 2026 | $1.18vs $1.16+1.7% | $3.2Bvs $2.8B+15.5% |
| Q3 2025 | Aug 5, 2025 | $0.67vs $0.86-21.7% | $3.0Bvs $1.5B+98.0% |
| Q1 2025 | Feb 25, 2025 | $0.23vs $0.92-75.5% | $3.0Bvs $1.5B+96.0% |
Based on last 12 quarters of dataView full earnings history →
SNN Peer Comparison
Smith & Nephew plc (SNN) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ZBH | 16.25B | 83.01 | 23.38 | 7.2% | 9.05% | 5.77% | 9.06% | 0.59 |
 SYK | 113.08B | 295.25 | 35.15 | 11.16% | 12.92% | 15.04% | 3.79% | 0.66 |
 BSX | 83.2B | 55.98 | 28.86 | 19.87% | 14.4% | 12.4% | 4.4% | 0.51 |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 10.37% | 5.42% | 0.52 |
 CNMD | 1.13B | 36.64 | 24.26 | 5.16% | 4% | 5.4% | 13.36% | 0.81 |
 MDT | 99.73B | 77.79 | 21.55 | 3.62% | 13% | 9.45% | 5.2% | 0.59 |
 JNJ | 543.64B | 225.59 | 38.96 | 4.3% | 27.26% | 31.69% | 3.65% | 0.51 |
 ABT | 151.59B | 87.18 | 11.41 | 4.59% | 31.88% | 27.26% | 4.19% | 0.32 |
Compare SNN vs Peers
Smith & Nephew plc (SNN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SNN Income Statement
Smith & Nephew plc (SNN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.76B | 4.9B | 5.14B | 4.56B | 5.21B | 5.21B | 5.55B | 5.81B | 6.18B | 11.61B |
| Revenue Growth % | 2.06% | 2.92% | 4.77% | -11.25% | 14.3% | 0.06% | 6.4% | 4.7% | 6.34% | 9.95% |
| Cost of Goods Sold | 1.25B | 1.3B | 1.34B | 1.4B | 1.54B | 1.54B | 1.73B | 1.76B | 1.98B | 3.46B |
| COGS % of Revenue | 26.19% | 26.47% | 26.04% | 30.61% | 29.6% | 29.53% | 31.18% | 30.36% | 31.99% | - |
| Gross Profit | 3.52B▲ 0% | 3.61B▲ 2.5% | 3.8B▲ 5.4% | 3.16B▼ 16.7% | 3.67B▲ 16.0% | 3.67B▲ 0.2% | 3.82B▲ 3.9% | 4.05B▲ 5.9% | 4.2B▲ 3.9% | 8.15B▲ 0% |
| Gross Margin % | 73.81% | 73.53% | 73.96% | 69.39% | 70.4% | 70.47% | 68.82% | 69.64% | 68.01% | 70.18% |
| Gross Profit Growth % | 3.53% | 2.53% | 5.38% | -16.74% | 15.96% | 0.16% | 3.92% | 5.94% | 3.85% | - |
| Operating Expenses | 2.58B | 2.74B | 2.98B | 2.87B | 3.08B | 3.23B | 3.39B | 3.39B | 3.2B | 6.92B |
| OpEx % of Revenue | 54.21% | 55.93% | 58.1% | 62.92% | 59.02% | 61.84% | 61.16% | 58.33% | 51.74% | - |
| Selling, General & Admin | 2.15B | 2.19B | 2.31B | 2.56B | 2.39B | 2.44B | 2.6B | 2.65B | 2.9B | 6.06B |
| SG&A % of Revenue | 45.16% | 44.6% | 45.04% | 56.18% | 45.93% | 46.69% | 46.89% | 45.65% | 46.93% | - |
| Research & Development | 223M | 246M | 292M | 307M | 356M | 345M | 299M | 289M | 296.69M | 652.29M |
| R&D % of Revenue | 4.68% | 5.02% | 5.68% | 6.73% | 6.83% | 6.62% | 5.39% | 4.97% | 4.8% | - |
| Other Operating Expenses | 202M | 176M | 0 | 0 | 0 | 0 | 205M | 448M | 0 | 0 |
| Operating Income | 934M▲ 0% | 863M▼ 7.6% | 815M▼ 5.6% | 295M▼ 63.8% | 593M▲ 101.0% | 315M▼ 46.9% | 425M▲ 34.9% | 657M▲ 54.6% | 1.01B▲ 53.0% | 1.5B▲ 0% |
| Operating Margin % | 19.6% | 17.6% | 15.86% | 6.47% | 11.38% | 6.04% | 7.66% | 11.31% | 16.27% | 12.91% |
| Operating Income Growth % | 16.6% | -7.6% | -5.56% | -63.8% | 101.02% | -46.88% | 34.92% | 54.59% | 53.02% | - |
| EBITDA | 1.39B | 1.32B | 1.33B | 840M | 1.16B | 863M | 952M | 1.24B | 1.58B | 2.49B |
| EBITDA Margin % | 29.25% | 26.86% | 25.94% | 18.42% | 22.18% | 16.55% | 17.16% | 21.29% | 25.57% | 21.46% |
| EBITDA Growth % | 8.99% | -5.52% | 1.21% | -36.98% | 37.62% | -25.35% | 10.31% | 29.94% | 27.7% | 7.43% |
| D&A (Non-Cash Add-back) | 460M | 454M | 518M | 545M | 563M | 548M | 527M | 580M | 574.34M | 993.46M |
| EBIT | 946M | 852M | 818M | 321M | 679M | 326M | 429M | 657M | 1.01B | 1.51B |
| Net Interest Income | -61M | -51M | -55M | -56M | -74M | -66M | -105M | -149M | -128.3M | -11.6M |
| Interest Income | 6M | 8M | 10M | 6M | 6M | 14M | 34M | 19M | 28.07M | 130.13M |
| Interest Expense | 67M | 59M | 65M | 62M | 80M | 80M | 139M | 168M | 156.36M | 172.78M |
| Other Income/Expense | -55M | -82M | -72M | -49M | -7M | -80M | -135M | -159M | -224.52M | -297.62M |
| Pretax Income | 879M▲ 0% | 781M▼ 11.1% | 743M▼ 4.9% | 246M▼ 66.9% | 586M▲ 138.2% | 235M▼ 59.9% | 290M▲ 23.4% | 498M▲ 71.7% | 780.82M▲ 56.8% | 944.27M▲ 0% |
| Pretax Margin % | 18.45% | 15.93% | 14.46% | 5.39% | 11.24% | 4.51% | 5.23% | 8.57% | 12.64% | 8.13% |
| Income Tax | 112M | 118M | 143M | -202M | 62M | 12M | 27M | 86M | 154.36M | 143.62M |
| Effective Tax Rate % | 12.74% | 15.11% | 19.25% | -82.11% | 10.58% | 5.11% | 9.31% | 17.27% | 19.77% | 15.21% |
| Net Income | 767M▲ 0% | 663M▼ 13.6% | 600M▼ 9.5% | 448M▼ 25.3% | 524M▲ 17.0% | 223M▼ 57.4% | 263M▲ 17.9% | 412M▲ 56.7% | 626.46M▲ 52.1% | 798.64M▲ 0% |
| Net Margin % | 16.1% | 13.52% | 11.68% | 9.82% | 10.05% | 4.28% | 4.74% | 7.09% | 10.14% | 6.88% |
| Net Income Growth % | -2.17% | -13.56% | -9.5% | -25.33% | 16.96% | -57.44% | 17.94% | 56.65% | 52.05% | 11.86% |
| Net Income (Continuing) | 767M | 663M | 600M | 448M | 524M | 223M | 263M | 412M | 626.46M | 800.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.76▲ 0% | 1.52▼ 13.6% | 1.36▼ 10.5% | 1.02▼ 25.0% | 1.20▲ 17.6% | 0.50▼ 58.3% | 1.20▲ 140.0% | 0.94▼ 21.7% | 1.44▲ 53.2% | 1.82▲ 0% |
| EPS Growth % | 0% | -13.64% | -10.53% | -25% | 17.65% | -58.33% | 140% | -21.67% | 53.19% | 14.2% |
| EPS (Basic) | 1.76 | 1.52 | 1.38 | 1.02 | 1.20 | 0.50 | 1.20 | 0.94 | 1.46 | - |
| Diluted Shares Outstanding | 437.55M | 437.55M | 437.55M | 437.55M | 438.86M | 437.55M | 218.44M | 438.3M | 436.47M | 439.94M |
| Basic Shares Outstanding | 437.55M | 437.55M | 437.55M | 437.55M | 438.5M | 437.55M | 217.75M | 438.3M | 433.42M | 436.75M |
| Dividend Payout Ratio | 35.07% | 48.42% | 53% | 73.21% | 62.79% | 146.64% | 124.33% | 79.37% | 52.8% | - |
SNN Balance Sheet
Smith & Nephew plc (SNN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 2.73B | 3.08B | 3.22B | 4.66B | 4.42B | 3.86B | 4.03B | 4.42B | 4.1B | 4.62B |
| Cash & Short-Term Investments | 169M | 365M | 277M | 1.76B | 1.29B | 350M | 302M | 619M | 557M | 675.41M |
| Cash Only | 169M | 365M | 277M | 1.76B | 1.29B | 350M | 302M | 619M | 557M | 675.41M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.06B | 1.1B | 1.08B | 911M | 971M | 1.03B | 1.06B | 1.21B | 1.43B | 1.48B |
| Days Sales Outstanding | 80.89 | 82.17 | 76.86 | 72.92 | 68 | 71.88 | 69.66 | 75.83 | 84.42 | 40.1 |
| Inventory | 1.3B | 1.4B | 1.61B | 1.69B | 1.84B | 2.21B | 2.4B | 2.39B | 2.12B | 2.46B |
| Days Inventory Outstanding | 381.38 | 392.28 | 440.29 | 442.13 | 436.2 | 522.61 | 505.3 | 493.91 | 390.92 | 256.6 |
| Other Current Assets | 120M | 144M | 171M | 219M | 240M | 198M | 182M | 81M | 0 | 0 |
| Total Non-Current Assets | 5.13B | 4.98B | 6.08B | 6.35B | 6.5B | 6.11B | 5.96B | 5.93B | 6.35B | 6.06B |
| Property, Plant & Equipment | 1.05B | 1.06B | 1.32B | 1.45B | 1.51B | 1.46B | 1.47B | 1.42B | 1.64B | 1.43B |
| Fixed Asset Turnover | 4.54x | 4.62x | 3.88x | 3.15x | 3.44x | 3.58x | 3.77x | 4.09x | 3.77x | 8.05x |
| Goodwill | 2.37B | 2.34B | 2.79B | 2.93B | 2.99B | 3.03B | 2.99B | 3.03B | 3.11B | 3.11B |
| Intangible Assets | 1.37B | 1.21B | 1.57B | 1.49B | 1.4B | 1.24B | 1.11B | 1.03B | 882M | 961.16M |
| Long-Term Investments | 201M | 231M | 216M | 250M | 380M | 58M | 24M | 16M | 151M | 168.97M |
| Other Non-Current Assets | 16M | 16M | 35M | 33M | 15M | 153M | 361M | 103M | 228M | 642.9M |
| Total Assets | 7.87B▲ 0% | 8.06B▲ 2.5% | 9.3B▲ 15.4% | 11.01B▲ 18.4% | 10.92B▼ 0.8% | 9.97B▼ 8.7% | 9.99B▲ 0.2% | 10.35B▲ 3.7% | 10.46B▲ 1.0% | 10.68B▲ 0% |
| Asset Turnover | 0.61x | 0.61x | 0.55x | 0.41x | 0.48x | 0.52x | 0.56x | 0.56x | 0.59x | 1.12x |
| Asset Growth % | 7.11% | 2.45% | 15.39% | 18.42% | -0.84% | -8.74% | 0.21% | 3.67% | 0.99% | 12.31% |
| Total Current Liabilities | 1.35B | 1.47B | 1.56B | 1.69B | 2.13B | 1.72B | 2.27B | 1.53B | 1.59B | 1.54B |
| Accounts Payable | 873M | 854M | 941M | 891M | 1.04B | 1.03B | 1.02B | 1.08B | 1.18B | 1.1B |
| Days Payables Outstanding | 255.32 | 240.15 | 256.7 | 232.96 | 246.72 | 243.89 | 214.36 | 223.88 | 217.34 | 111.15 |
| Short-Term Debt | 29M | 167M | 26M | 279M | 435M | 111M | 710M | 2M | 150M | 156.86M |
| Deferred Revenue (Current) | 149M | 223M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 444M | 444M | 551M | 460M | 597M | 526M | 261M | 126M | 74M | 57.95M |
| Current Ratio | 2.03x | 2.10x | 2.06x | 2.76x | 2.08x | 2.25x | 1.77x | 2.89x | 2.57x | 2.57x |
| Quick Ratio | 1.06x | 1.15x | 1.03x | 1.76x | 1.21x | 0.96x | 0.72x | 1.33x | 1.25x | 1.25x |
| Cash Conversion Cycle | 206.94 | 234.3 | 260.46 | 282.09 | 257.48 | 350.61 | 360.6 | 345.85 | 258 | 185.56 |
| Total Non-Current Liabilities | 1.88B | 1.72B | 2.59B | 4.04B | 3.22B | 2.99B | 2.5B | 3.56B | 3.57B | 3.61B |
| Long-Term Debt | 1.42B | 1.3B | 1.85B | 3.2B | 2.71B | 2.56B | 2.17B | 3.12B | 3.03B | 3.15B |
| Capital Lease Obligations | 0 | 0 | 124M | 157M | 141M | 147M | 144M | 135M | 149M | 554.87M |
| Deferred Tax Liabilities | 97M | 99M | 167M | 141M | 144M | 36M | 0 | 0 | 40M | 50.96M |
| Other Non-Current Liabilities | 453M | 419M | 452M | 551M | 229M | 244M | 180M | 300M | 356M | 1.04B |
| Total Liabilities | 3.22B | 3.19B | 4.16B | 5.73B | 5.35B | 4.71B | 4.77B | 5.09B | 5.17B | 5.15B |
| Total Debt | 1.45B | 1.47B | 2.05B | 3.69B | 3.34B | 2.87B | 3.08B | 3.32B | 3.33B | 3.45B |
| Net Debt | 1.28B | 1.1B | 1.77B | 1.93B | 2.05B | 2.52B | 2.78B | 2.7B | 2.77B | 2.78B |
| Debt / Equity | 0.31x | 0.30x | 0.40x | 0.70x | 0.60x | 0.55x | 0.59x | 0.63x | 0.63x | 0.63x |
| Debt / EBITDA | 1.04x | 1.11x | 1.54x | 4.39x | 2.89x | 3.33x | 3.24x | 2.68x | 2.11x | 1.38x |
| Net Debt / EBITDA | 0.92x | 0.84x | 1.33x | 2.30x | 1.77x | 2.92x | 2.92x | 2.18x | 1.75x | 1.75x |
| Interest Coverage | 13.94x | 14.63x | 12.54x | 4.76x | 7.41x | 3.94x | 3.06x | 3.91x | 6.43x | 8.75x |
| Total Equity | 4.64B▲ 0% | 4.87B▲ 5.0% | 5.14B▲ 5.5% | 5.28B▲ 2.7% | 5.57B▲ 5.5% | 5.26B▼ 5.5% | 5.22B▼ 0.8% | 5.26B▲ 0.9% | 5.29B▲ 0.5% | 5.53B▲ 0% |
| Equity Growth % | 17.33% | 4.95% | 5.48% | 2.68% | 5.47% | -5.55% | -0.8% | 0.92% | 0.46% | 5.85% |
| Book Value per Share | 10.61 | 11.14 | 11.75 | 12.06 | 12.69 | 12.02 | 23.88 | 12.01 | 12.12 | 12.57 |
| Total Shareholders' Equity | 4.64B | 4.87B | 5.14B | 5.28B | 5.57B | 5.26B | 5.22B | 5.26B | 5.29B | 5.53B |
| Common Stock | 178M | 177M | 177M | 177M | 177M | 175M | 175M | 175M | 175M | 174.85M |
| Retained Earnings | 4.33B | 4.63B | 4.85B | 4.96B | 5.22B | 5.03B | 4.91B | 5.02B | 5.32B | 5.12B |
| Treasury Stock | -257M | -214M | -189M | -157M | -120M | -118M | -94M | -66M | -515M | -47.96M |
| Accumulated OCI | -211M | -322M | -306M | -311M | -328M | -439M | -385M | 0 | 20M | -326.71M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNN Cash Flow Statement
Smith & Nephew plc (SNN) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.09B | 931M | 1.17B | 935M | 877M | 468M | 608M | 987M | 1.29B | 1.29B |
| Operating CF Margin % | 22.88% | 18.98% | 22.73% | 20.5% | 16.83% | 8.97% | 10.96% | 16.99% | 20.85% | - |
| Operating CF Growth % | 28.39% | -14.59% | 25.46% | -19.95% | -6.2% | -46.64% | 29.91% | 62.34% | 30.5% | 319.48% |
| Net Income | 879M | 781M | 743M | 246M | 586M | 235M | 290M | 412M | 626.46M | 798.64M |
| Depreciation & Amortization | 460M | 454M | 518M | 596M | 581M | 628M | 527M | 580M | 574.34M | 1.05B |
| Stock-Based Compensation | 31M | 35M | 32M | 26M | 41M | 40M | 39M | 40M | 0 | 60M |
| Deferred Taxes | -229M | -201M | -207M | -50M | -255M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 51M | 51M | 55M | 56M | 74M | 100M | 84M | 78M | -40.09M | 111.87M |
| Working Capital Changes | -102M | -189M | 27M | 61M | -150M | -535M | -332M | -123M | 127.3M | -134.41M |
| Change in Receivables | -40M | -108M | 30M | 209M | -81M | -103M | -49M | -81M | -175.41M | -179.44M |
| Change in Inventory | -17M | -152M | -204M | -45M | -151M | -407M | -178M | -42M | 208.49M | -220M |
| Change in Payables | 0 | 0 | -30M | -209M | 81M | 103M | 0 | 0 | 94.22M | -107.97M |
| Cash from Investing | -543M | -378M | -1.25B | -606M | -691M | -472M | -448M | -569M | -406.95M | -971.22M |
| Capital Expenditures | -376M | -347M | -408M | -443M | -408M | -358M | -427M | -381M | -434.01M | -781.25M |
| CapEx % of Revenue | 7.89% | 7.08% | 7.94% | 9.71% | 7.83% | 6.86% | 7.7% | 6.56% | 7.02% | - |
| Acquisitions | -159M | -29M | -869M | -170M | -285M | -113M | -21M | -186M | 29.07M | -187.96M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -376M | -345M | 26M | 7M | -404M | 1M | 0 | -2M | 0 | 0 |
| Cash from Financing | -434M | -371M | 7M | 1.16B | -645M | -926M | -200M | -86M | -957.23M | -418.96M |
| Debt Issued (Net) | -147M | -1M | 425M | 1.54B | -267M | -396M | 175M | 295M | -86.2M | -290.71M |
| Equity Issued (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | 0 | 1000K | -1000K | 562 |
| Dividends Paid | -269M | -321M | -318M | -328M | -329M | -327M | -327M | -327M | -330.77M | -656.82M |
| Share Repurchases | -52M | -48M | -63M | -16M | 0 | -158M | 0 | 0 | -503.17M | -1M |
| Other Financing | 24M | -14M | -37M | -37M | -63M | -51M | -48M | -55M | -49.11M | 528.7M |
| Net Change in Cash | 117M▲ 0% | 178M▲ 52.1% | -76M▼ 142.7% | 1.49B▲ 2065.8% | -466M▼ 131.2% | -941M▼ 101.9% | -44M▲ 95.3% | 317M▲ 820.5% | -62M▼ 119.6% | -492.59M▲ 0% |
| Free Cash Flow | 714M▲ 0% | 584M▼ 18.2% | 760M▲ 30.1% | 492M▼ 35.3% | 469M▼ 4.7% | 110M▼ 76.5% | 181M▲ 64.5% | 606M▲ 234.8% | 853.99M▲ 40.9% | 1.1B▲ 0% |
| FCF Margin % | 14.98% | 11.91% | 14.79% | 10.79% | 9% | 2.11% | 3.26% | 10.43% | 13.82% | 9.48% |
| FCF Growth % | 56.24% | -18.21% | 30.14% | -35.26% | -4.67% | -76.55% | 64.55% | 234.81% | 40.92% | 226.5% |
| FCF per Share | 1.63 | 1.33 | 1.74 | 1.12 | 1.07 | 0.25 | 0.83 | 1.38 | 1.96 | 1.96 |
| FCF Conversion (FCF/Net Income) | 1.42x | 1.40x | 1.95x | 2.09x | 1.67x | 2.10x | 2.31x | 2.40x | 2.06x | 1.38x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140M | 0 | 75M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNN Key Ratios
Smith & Nephew plc (SNN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 17.83% | 13.93% | 11.98% | 8.6% | 9.66% | 4.12% | 5.02% | 7.86% | 11.87% | 15.06% |
| Return on Invested Capital (ROIC) | 12.25% | 10.88% | 9.49% | 3.13% | 6% | 3.07% | 4.04% | 6.17% | 9.41% | 9.41% |
| Gross Margin | 73.81% | 73.53% | 73.96% | 69.39% | 70.4% | 70.47% | 68.82% | 69.64% | 68.01% | 70.18% |
| Net Margin | 16.1% | 13.52% | 11.68% | 9.82% | 10.05% | 4.28% | 4.74% | 7.09% | 10.14% | 6.88% |
| Debt / Equity | 0.31x | 0.30x | 0.40x | 0.70x | 0.60x | 0.55x | 0.59x | 0.63x | 0.63x | 0.63x |
| Interest Coverage | 13.94x | 14.63x | 12.54x | 4.76x | 7.41x | 3.94x | 3.06x | 3.91x | 6.43x | 8.75x |
| FCF Conversion | 1.42x | 1.40x | 1.95x | 2.09x | 1.67x | 2.10x | 2.31x | 2.40x | 2.06x | 1.38x |
| Revenue Growth | 2.06% | 2.92% | 4.77% | -11.25% | 14.3% | 0.06% | 6.4% | 4.7% | 6.34% | 9.95% |
SNN Frequently Asked Questions
Smith & Nephew plc (SNN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Smith & Nephew plc (SNN) reported $11.61B in revenue for fiscal year 2025. This represents a 534% increase from $1.83B in 1996.
Smith & Nephew plc (SNN) grew revenue by 6.3% over the past year. This is steady growth.
Yes, Smith & Nephew plc (SNN) is profitable, generating $798.6M in net income for fiscal year 2025 (10.1% net margin).
Dividend & Returns
Yes, Smith & Nephew plc (SNN) pays a dividend with a yield of 2.42%. This makes it attractive for income-focused investors.
Smith & Nephew plc (SNN) has a return on equity (ROE) of 11.9%. This is reasonable for most industries.
Smith & Nephew plc (SNN) generated $1.10B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More SNN
Smith & Nephew plc (SNN) financial analysis — history, returns, DCA and operating performance tools
Full SNN Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates